Novo Nordisk remains the GLP-1 leader with over 65% market share. Read an in-depth BVO stock analysis and why we rate it as a ...

Lundin Gold Inc. was the biggest leader among large stocks during the session, surging 10.8%, and Tomra Systems ASA increased 8.5%. Novo Nordisk A/S rounded out the top three leaders on Friday, with ...

Genmab Announces Financial Results for the First Half of 2025August 7, 2025 Copenhagen, Denmark; Interim Report for the First Half Ended June 30, 2025HighlightsEpcoritamab advancing to earlier lines ...

Mærsk A/S has decided to launch a share buy-back program of up to DKK 14.4 billion (around USD 2 billion) to be executed over ...

THIS ANNOUNCEMENT INCLUDES PUBLICATION OF INSIDE INFORMATION. We lower our 2025 revenue guidance to a range of between DKK 11.75bn and 12.25bn (previously DKK 12.3bn to 12.8bn), and our 2025 EBITDA ...

Novo Nordisk has been losing big in the past year and is down over 66% from its peak in 2024. On the other hand, Eli Lilly ...

Innovation Fund Denmark invests DKK 26 mln in U-SHIELD underwater security project. Find the latest news from the maritime industry on the PortNews website.

Q2 2025 Earnings Call Transcript August 6, 2025 Operator: Good day, and thank you for standing by. Welcome to the Q2 2025 ...

Novo Nordisk continues to deliver double-digit revenue and profit growth, driven by both its diabetes and obesity drug ...

AP Moller-Maersk shares rose in Copenhagen after the company reported strong earnings for the second quarter.

Initiates second phase of share buy-back program As announced on 5 February 2025, A.P. Møller - Mærsk A/S (the “Company”) has decided to launch a share buy-back program of up to DKK 14.4 billion ...